Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
HSCS | US
0.01
0.49%
Healthcare
Health Care Providers & Services
31/07/2024
24/04/2026
2.05
2.06
2.07
2.05
Heart Test Laboratories Inc. a medical technology company provides cardiovascular diagnostic devices. The company offers MyoVista wavECG a resting 12-lead electrocardiograph (ECG) to provide diagnostic information related to cardiac dysfunction as well as conventional 12-lead resting ECG information. It serves clinics doctor's offices urgent care centers and hospitals. The company was incorporated in 2007 and is headquartered in Southlake Texas.
View LessLow Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Value Stock (Price to Book < 3)
Strong Revenue Growth (> 10%)
High 6-Month Volatility (>65%)
Microcap (<300M USD)
High Market Beta (> 0.8)
Weak Operating Margin (< 10%)
Weak Sharpe Ratio (< 0.3)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
52.6%1 month
65.3%3 months
55.1%6 months
76.9%-
-
0.55
0.17
0.12
-0.14
46.26
-
-7.02M
1.87M
1.87M
-
-37.91K
-
653.80
-269.29
0.10
11.27
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
Range10D
0.43
Range1M
0.68
Range3M
1.63
Rel. volume
0.46
Price X volume
22.27K
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
No data | |||||||
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
No data | |||||||
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -0.14 | - | - |
| Ent. to Revenue | 46.26 | - | - |
| PE Ratio | - | - | - |
| Price to Book | 0.55 | - | - |
| Dividend Yield | - | - | - |
| Std. Deviation (3M) | 55.06 | - | - |
| Debt to Equity | 0.17 | - | - |
| Debt to Assets | 0.12 | - | - |
| Market Cap | 1.87M | - | - |